浙江省第二中医院，即浙江省立同德医院，位于杭州市古翠路234号，创办于1994年6月，是“九五”期间浙江省政府重点建设单位，为综合性三级甲等中医医院。

During the past decade, Tongde Hospital of Zhejiang Province conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tongde Hospital of Zhejiang Province" #1 sponsor was "Green Valley (Shanghai) Pharmaceuticals Co., Ltd." with 2 trials, followed by "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 2 trials sponsored, "China Resources Sanjiu Medical & Pharmaceutical Co., Ltd." with 1 trials sponsored, "Chinese PLA General Hospital" with 1 trials sponsored and "Peking University People's Hospital" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tongde Hospital of Zhejiang Province" #1 collaborator was "Affiliated Taihe Hospital of Hubei University of Medicine" with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Beijing Chao Yang Hospital" with 1 trials as a collaborator, "Beijing Friendship Hospital" with 1 trials as a collaborator and "Beijing Hospital" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Tongde Hospital of Zhejiang Province" are "Alzheimer Disease" (2 trials), "Acute Heart Failure" (1 trials), "Acute Ischemic Stroke AIS" (1 trials), "Bipolar I Depression" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Tongde Hospital of Zhejiang Province" in a lesser frequency.

Most popular intervention types in "Tongde Hospital of Zhejiang Province" are "Drug" (9 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5% glucose injection" (1 trials), "Anisodine Hydrobromide" (1 trials), "Anisodine Hydrobromide placebo" (1 trials) and "Heart-protecting Musk Pill" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tongde Hospital of Zhejiang Province" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Tongde Hospital of Zhejiang Province". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tongde Hospital of Zhejiang Province, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tongde Hospital of Zhejiang Province, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".